- Title
- Management of type 2 diabetes mellitus : a pharmacoepidemiological review
- Creator
- Saugur, Anusooya
- Subject
- Diabetes
- Subject
- Diabetes -- Management
- Subject
- Diabetes -- Diet therapy
- Subject
- Diabetes -- Prevention
- Subject
- Insulin -- Therapeutic use
- Subject
- Hypoglycemia
- Date Issued
- 2011
- Date
- 2011
- Type
- Thesis
- Type
- Masters
- Type
- MPharm
- Identifier
- vital:10129
- Identifier
- http://hdl.handle.net/10948/1635
- Identifier
- Diabetes
- Identifier
- Diabetes -- Management
- Identifier
- Diabetes -- Diet therapy
- Identifier
- Diabetes -- Prevention
- Identifier
- Insulin -- Therapeutic use
- Identifier
- Hypoglycemia
- Description
- Type 2 diabetes mellitus (DM) is a progressive disease characterised by hyperglycaemia caused by defects in insulin secretion and insulin action. In early stages of type 2 DM, dietary and lifestyle changes are often sufficient to control blood glucose levels. However, over time, many patients experience β cell dysfunction and require insulin therapy, either alone or in combination with oral agents. There are guidelines available to structure the management of this disease state, including both the use of oral hypoglycaemic agents and or insulin. Besides health complications, there are economic burdens associated with the management of type 2 diabetes mellitus. The aim of this study was to determine the management of type 2 DM in a South African sample group of patients drawn from a large medical aid database. The objectives of the study were: to establish the prevalence of type 2 DM relative to age, examine the nature of chronic comorbid disease states, establish trends in the prescribing of insulin relative to other oral hypoglycaemic agents, investigate cost implications, and determine trends in the use of blood and urine monitoring materials by patients. The study was quantitative and retrospective and descriptive statistics were used in the analysis. DM was found to be most prevalent amongst patients between 50 and 59 years old. Results also demonstrated that 83% of DM patients also suffered from other chronic comorbid diseases, with cardiovascular diseases, especially hypertension and hypercholesterolaemia being the most prominent. This study also revealed that DM is predominantly managed with oral hypoglycaemic agents. Changes in drug prescribing, for chronic disease states such as DM may have medical, social and economic implications both for individual patients and for society and it is envisaged that the results of this study can be used to influence future management of DM. Keywords: Pharmacoepidemiology, management, type 2 diabetes mellitus
- Format
- ix, 171 leaves ; 31 cm
- Format
- Publisher
- Nelson Mandela Metropolitan University
- Publisher
- Faculty of Health Sciences
- Language
- English
- Rights
- Nelson Mandela Metropolitan University
- Hits: 1596
- Visitors: 1831
- Downloads: 307
Thumbnail | File | Description | Size | Format | |||
---|---|---|---|---|---|---|---|
View Details Download | SOURCEPDF | 1 MB | Adobe Acrobat PDF | View Details Download |